Navigation Links
Media in Medical Technology

SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production

ST. LOUIS, April 23 /PRNewswire-FirstCall/ -- SAFC Biosciences(R), a business segment within SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL ), today announced the introduction of EX-CELL(TM) EBx (R) cell growth and viral production media designed exclusively to support Vivalis' (NY...

Mindset Media Study Reveals Which Independent Voters Favor Obama Vs. McCain

Study Finds That Self-Proclaimed Independent Voters Who Score High in Creativity Skew toward Obama and Very Optimistic Independents Prefer McCain NEW YORK, Oct. 20 /PRNewswire/ -- Mindset Media (http://www.mindset-media.com ), which operates an online ad network that enables brand advertise...

News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments

FLINT, Mich., Oct. 7 /PRNewswire/ -- McLaren Health Care and its Great Lakes Cancer Institute are gathering some of the world's leading medical minds to share the latest work underway around the globe on breast and gastrointestinal cancer treatments. The October 11th symposium, hosted by McLar...

ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia

SYDNEY, Australia, Sept. 30 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that a marketing application for the mucus clearing agent, Bronchitol, has been submitted to the Therapeutic Goods Administration (TGA) division of the Austral...

Cardium and Tissue Repair Company's Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.

SAN DIEGO, March 17 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM ) and its subsidiary, Tissue Repair Company (TRC) today reported that the Phase 2b MATRIX clinical study has been the focus of media attention in multiple regions across the U.S., including television news features ...

Hospital to Hold MRSA Briefing for Media and Community Leaders

Dr. James Rahal, Infectious Disease Specialist, also available as Expert Resource FLUSHING, N.Y., Oct. 30 /PRNewswire-USNewswire/ -- The following is being issued by New York Hospital Queens: WHAT: A special briefing on methicillin-resistant Staphylococcus aureus(MRSA) i...

Regular Yoga Practice Is Associated With Mindful Eating

...isit fhcrc.org. This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com. media Contacts: Kristen Woodward 206-667-5095 kwoodwar@fhcrc.org ...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

...forward-looking information or statements. Contacts Global media Relations US media Relations Pascal Barollier Donna Cary T. +33-...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

... Director Corporate Affairs & Communication Tel: +41(0)21-321-01-11 Fax: +41(0)21-321-01-69 mwagner@debiopharm.com Additional media Contacts: In London Maitland Brian Hudspith Tel: +44(0)20-7379-5151 bhudspith@maitland.co.uk In New York Russo Partner...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

...n contained in this release. For Tower: Company Contact: Melinda Jarrell +1-949-435-8181 melinda.jarrell@tower-usa.com media Contact: Lauri Julian +1-949-715-3049 lauri.julian@jazzsemi.com Investor Relations Contact: Noit Levi +972-4-604-7066 ...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

... Investor Relations Clea Rosenfeld (Rest of the World) +44-1256-894-160 Eric Rojas (North America) +1-617-551-9715 media Jessica Mann (Rest of the World) +44-1256-894-280 Jessica Cotrone (North America) +1-617-613-4640 ...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

...CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise. media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 E: deramian@ctiseattle.com www.CellTherapeutics.com/press_room Investo...

FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents

... Investor Relations Clea Rosenfeld (Rest of the World) +44-1256-894-160 Eric Rojas (North America) +1-617-551-9715 media Jessica Mann (Rest of the World) +44-1256-894-280 Matthew Cabrey (North America) +1-484-595-8248 ...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

...t Reports on Form 8-K filed by the Company. Contact: General media Inquiries Kristin O'Neill 312-233-1295 Kristin.Oneill@edelman.com Financial media Inquiries: Cryo-Cell International, Inc. Investor Relations Dia...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

...obligation to update forward-looking statements. Contact: Raul Rodriguez Phone: 650.624.1302 Email: rrodriguez@rigel.com media Contact: Susan C. Rogers, Alchemy Consulting, Inc. Phone: 650.430.3777 Email: susan@alchemyemailbox.com ...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

... New York City's economy. In recent months, we've announced initiatives to promote entrepreneurship, develop green jobs, support nonprofits, grow the media industry and add industrial jobs, and today's announcement affirms our belief that bioscience is another industry in which the City can and will succe...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... Director Corporate Affairs & Communication Tel.: +41(0)21-321-01-11 Fax: +41(0)21-321-01-69 mwagner@debiopharm.com Additional media Contacts: In London: Maitland Brian Hudspith Tel: +44(0)20-7379-5151 bhudspith@maitland.co.uk In New York: Russo Partn...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... Director Corporate Affairs & Communication Tel.: +41(0)21-321-01-11 Fax: +41(0)21-321-01-69 mwagner@debiopharm.com Additional media Contacts: In London: Maitland Brian Hudspith Tel: +44(0)20-7379-5151 bhudspith@maitland.co.uk In New York: Russo Partn...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com . Novartis US media Contacts Kimberly Willard Anna Frable Novartis Pharmaceuticals Corporation Novartis Pharmaceuticals Corporation 862...

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

...es not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise. media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 E: deramian@ctiseattle.com www.CellTherapeutics.com/press_room Investo...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

...ke any obligation to update forward-looking statements. Contact: Raul Rodriguez Phone: 650.624.1302 Email: rrodriguez@rigel.com media Contact: Susan C. Rogers, Alchemy Consulting, Inc. Phone: 650.430.3777 Email: susan@alchemyemailbox.com ...

Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis

...ritis, thrombocytopenia and asthma, as well as in cancer. Contact: Raul Rodriguez Phone: 650.624.1302 Email: invrel@rigel.com media Contact: Susan C. Rogers, Alchemy Consulting, Inc. Phone: 650.430.3777 Email: susan@alchemyemail.com ...

USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic

... several promising discoveries in the field of oncology licensed from USC . For more information, visit www.pivotalbiosciences.com . media Inquiries: Elisa Wiefel Schreiber Leslie Ridgeway USC Stevens Institute for Innovation Keck School of Medicine of USC Un...

Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets

... in over 80 countries worldwide. Please visit http://www.pg.com for the latest news and in-depth information about P&G and its brands. media Contacts: Scott Docherty - P&G Pharmaceuticals, Inc. +1-513-622-0478 Danielle Catapano - MSL Worldwide, PR +1-212-468-3...

Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease

... Investor Relations Clea Rosenfeld (Rest of the World) +44-1256-894-160 Eric Rojas (North America) +1-617-551-9715 media Jessica Mann (Rest of the World) +44-1256-894-280 Matthew Cabrey (North America) +1-484-595-8248 ...

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)

...Society (AES) Congress, 5-9 December 2009, Seattle, WA, USA (Epilepsia, 49(Suppl. 7), 1-498, 2008). For further information please contact media contacts For more information please contact: BIAL (head office) Francisco Osório Tel.: +351-22-986-6100 Mobile: +351-96-346-9968...

MADIT-CRT Trial Meets Primary Endpoint

...DIT-II, CONTAK-CD and COMPANION. CONTACT: Paul Donovan 508-650-8541 (office) 508-667-5165 (mobile) media Relations Boston Scientific Corporation Larry Neumann 508-650-8696 (office) Investor Relations ...

Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries

... Director Corporate Affairs & Communication Tel.: +41(0)21-321-01-11 Fax: +41(0)21-321-01-69 mwagner@debiopharm.com Additional media Contacts In London Maitland Brian Hudspith Tel: +44(0)20-7379-5151 bhudspith@maitland.co.uk In New York Russo Partners,...

Inspiration for 'My Sister's Keeper' Speaks Out

... create an embryo that could save a sibling's life. The bioethical issues raised by the case led to extensive, in-depth coverage in nearly every major media outlet in the world. The coverage caught the eye of author Picoult, who used it as a jumping off point for her novel, My Sister's Keeper. "We str...

Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th

..., CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 E: media@ctiseattle.com www.CellTherapeutics.com/press_room Investors ...

Alfacell Provides Shareholder Update

...ing statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release. media and Investor Contact: Charles Muniz Alfacell Corporation 732-652-4525 info@alfacell.com ...

China Animal Welfare Law Under Review While 36,000 Dogs Culled

... BEIJING, June 16 /PRNewswire-USNewswire/ -- Today the Chinese state media announced that the dog cull in Hanzhong city, Shaanxi Province has reached a death toll of 36,000. Claiming rabies outbreak, the city has sent out dog...

EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health

..., PhD CEO EUCODIS Bioscience Brunner Strasse 59 A-1230 Vienna AUSTRIA +43-1-86634-9241 office@eucodisbioscience.com media contact EUCODIS Bioscience: Frank Butschbacher Investor Relations & Communications http://www.butschbacher.net +43-650-7844940 ...

Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome

... a selective immunoproteasome inhibitor. For additional information on Proteolix, please visit www.proteolix.com . Contact information media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. Bergman or Michelle Corr...

UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients

...lthcare Venture, Teva Pharmaceuticals, Amgen, Denali Ventures and Auriga Ventures. CONTACT: Courtney McCrimmon Wendy Zellner UPMC media Relations PHONE: +1-412-647-3555 E-MAIL: McCrimmonCP@upmc.edu ZellnerWL@upmc.edu CONTACT: Marjie Hadad Gamida Cell ...

When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research

...s Whole Foods, PCC, NRG and Pharmaca, as well as online at www.naturalhi.com . For more information on NHI, the Femmenessence product line, or media related inquiries, contact Jennifer Bryan 805-962-1347 or at jbryan@christiecomm.com " target="_new"> jbryan@christiecomm.com . ...

Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System

... Cepheid, and Cepheid assumes no obligation to update any such forward-looking statement or reasons why results might differ. CONTACTS: For media Inquiries: For Cepheid Investor Inquiries: Jared Tipton Jacquie Ross Cepheid Corporate Communica...

Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Care Options

...portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com . media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 E: deramian@ctiseattle.com www.CellTherapeutics.com/press_room Invest...

FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight

...r revise the information contained in this announcement whether as a result of new information, future events or circumstances or otherwise. media Contact: Jerry Parrott Vice President, Corporate Communications 301-315-2777 Investor Contact: Peter Vozzo Senior Director, I...

Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery

...4, 2009, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws. media Contact: Dana Banks, Masimo Corporation 949-297-7348 Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing C...
Other Tags
(Date:8/21/2014)... Algae might seem easy to ignore, but they are ... animals depend upon. Humans are increasingly dependent on algae, ... atmosphere and sink it to the bottom of the ... and laboratory experiments, researchers have evidence showing that viruses ... the algae,s blooms, even when all else stays essentially ...
(Date:8/21/2014)... researchers from Beth Israel Deaconess Medical Center (BIDMC ) ... Most Influential Scientific Minds 2014," a comprehensive list ... web resource for science metrics and research performance analysis. ... most influential "are performing and publishing work that their ... science," according to a Thomson Reuters statement. Researchers were ...
(Date:8/21/2014)... 2014 , WHERE: , San Diego Convention ... 92101 , WHAT: , Invited and platform ... research in human genetics. Examples of sessions include: ... rare genetic variants in health and disease, the ... sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , Crowdsourced ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3American Society of Human Genetics 2014 Annual Meeting 2
(Date:8/23/2014)... Los Angeles, CA (PRWEB) August 23, 2014 ... binary options trading system created by Greg Marks has ... public launch earlier this month. The commotion surrounding the ... Hendricks, prompting an investigative review. , “In ... binary options trading software systems, commonly referred to as ...
(Date:8/23/2014)... The MPWMD Board of Directors voted on Monday, ... sole source of water for commercial and industrial properties. ... Brown of Archworks, LLC in Carmel, California. , This ... a water district in the State of California has approved ... AWGs at this time can now be used as a ...
(Date:8/23/2014)... Young adults in Athens, GA who find that ... up the phone and call the new helpline which can offer ... , Troubled Teen Athens is a wonderful resource for an ... the necessary steps to end substance abuse once and for all. ... to friends or peers when really they should put their faith ...
(Date:8/23/2014)... NC (PRWEB) August 23, 2014 Teen ... North Carolina. It’s no different in Wilmington, NC. Substance ... adults are falling victim to drug and alcohol dependency ... people are looking to overcome substance abuse, but don’t ... an adolescent treatment facility can be a challenge because ...
(Date:8/22/2014)... Search Engine Optimization is needed ... of search engines and get more audience and ... compared many Linux hosting suppliers and announced that ... most recommended Linux hosting suppliers for webmasters from ... buy high quality Linux hosting (including VPS and ...
Breaking Medicine News(10 mins):Health News:Legal Insider Bot Review Examining Greg Marks’ Trading Software Released 2Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:Teenagers in Athens, GA are Locating Addiction Recovery Thanks to New Helpline 2Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2Health News:Top10BestSEOHosting.com Announces Best Cheap Hosting Suppliers Of This Summer 2
Other Contents